HomeNDC LookupDrug shortages › Furosemide Injection

Furosemide Injection shortage

Furosemide Injection is currently listed in shortage by the FDA. The FDA lists 30 affected products. The reported reason: Other; Requirements related to complying with good manufacturing practices; Discontinuation of the manufacture of the drug. This page was last refreshed from FDA data on Sep 18, 2026.

Current ⚠ Supply risk: Medium Cardiovascular 30 products 8 manufacturers 2,355 days · 6.5 yr First posted Apr 7, 2020 Updated Sep 17, 2026
Here’s the bottom line

Furosemide injection is in shortage, with the 20 mg/2 mL strength currently having no available source. Most other strengths remain listed by manufacturers not reporting a shortage.

Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).

Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →
30
Affected NDCs
8
Reporting manufacturers
6/8
Reporting mfrs supplying
7/8
Affected strengths / sizes supplied
44%
NDCs unavailable
2,355
Days in shortage
28,042
Medicaid Rx (2025)
Source: FDA Drug Shortages Database API (openFDA). Last refreshed Sep 18, 2026 · today

What’s in shortage — at a glance

These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Furosemide Injection. Other makers that haven’t reported a problem are shown in the green card below.

Availability of affected NDCs
From the FDA shortage report
30 NDCs
Available 15 Unavailable 12 To be discontinued 3
Affected strengths / sizes still supplied
Among manufacturers reporting this shortage
7/8 strengths / sizes
Sourceable 7 No supply 1
FDA-reporting manufacturers with supply
Among manufacturers reporting this shortage
6/8 makers
With supply 6 No supply 2
✓ Other manufacturers not reporting a shortage
Still-marketed Furosemide Injection from companies that have not filed an FDA shortage — these are not counted in the figures above. Stock can still vary by pharmacy.
Hikma Pharmaceuticals USA Inc. Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. Sagent Pharmaceuticals Camber Pharmaceuticals, Inc. Baxter Healthcare Corporation Fresenius Kabi USA, LLC Amneal Pharmaceuticals LLC REMEDYREPACK INC. Lifestar Pharma LLC Meitheal Pharmaceuticals Inc.
Plus 9 alternative dosage forms of Furosemide.
See all other options & details →
Shortage timeline
  1. Sep 17, 2026
    Currently in shortage
    30 of 30 products affected.
  2. Sep 15, 2026
    FDA refreshed this shortage record
    6 products updated.
  3. Sep 9, 2026
    FDA refreshed this shortage record
    6 products updated.
  4. Sep 1, 2026
    FDA refreshed this shortage record
    3 products updated.
  5. Aug 27, 2026
    FDA refreshed this shortage record
    3 products updated.
  6. Jul 22, 2026
    FDA refreshed this shortage record
    3 products updated.
  7. Apr 28, 2026
    FDA refreshed this shortage record
    3 products updated.
  8. Apr 28, 2026
    More presentations reported
    3 more products added to the shortage.
  9. Apr 7, 2020
    First reported to the FDA
    27 products first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

What exactly is on backorder — by manufacturer

Manufacturer: Accord Healthcare Inc. 📞 866-941-7875 3 NDCS click to expand
Status NDC / product Strength / size Availability Related information Reason
Current Furosemide, Injection, 10 mg/1 mL (NDC 16729-501-43) NDC 16729-0501-43 Unavailable Estimated recovery: TBD Requirements related to complying with good manufacturing pr...
Current Furosemide, Injection, 10 mg/1 mL (NDC 16729-500-08) NDC 16729-0500-08 Unavailable Estimated recovery: TBD Requirements related to complying with good manufacturing pr...
Current Furosemide, Injection, 10 mg/1 mL (NDC 16729-502-43) NDC 16729-0502-43 Unavailable Estimated recovery: TBD Requirements related to complying with good manufacturing pr...
Manufacturer: Avet Pharmaceuticals, Inc. 📞 855-228-9470 3 NDCS click to expand
Status NDC / product Strength / size Availability Related information Reason
Current Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-44) NDC 23155-0473-44 Unavailable Estimated recovery: End October 2026; Manufacturing delay Other
Current Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-42) NDC 23155-0473-42 Unavailable Estimated recovery: End October 2026; Manufacturing delay Other
Current Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-41) NDC 23155-0473-41 Available
Manufacturer: Baxter Healthcare 📞 888-229-0001 3 NDCS click to expand
Status NDC / product Strength / size Availability Related information Reason
Current Furosemide, Injection, 10 mg/1 mL (NDC 36000-283-25) NDC 36000-0283-25 Available
Current Furosemide, Injection, 10 mg/1 mL (NDC 36000-282-25) NDC 36000-0282-25 Available
Current Furosemide, Injection, 10 mg/1 mL (NDC 36000-284-25) NDC 36000-0284-25 Available
Manufacturer: Eugia US LLC 📞 888-238-7880 3 NDCS click to expand
Status NDC / product Strength / size Availability Related information Reason
Current Furosemide, Injection, 20 mg/2 mL (NDC 55150-322-25) NDC 55150-0322-25 Unavailable On backorder. Recovery: TBD. Check wholesalers for inventory Demand increase for the drug
Current Furosemide, Injection, 100 mg/10 mL (NDC 55150-324-25) NDC 55150-0324-25 Available Check wholesalers for inventory
Current Furosemide, Injection, 40 mg/4 mL (NDC 55150-323-25) NDC 55150-0323-25 Available Check wholesalers for inventory
Manufacturer: Fresenius Kabi USA, LLC 📞 888-386-1300 3 NDCS click to expand
Status NDC / product Strength / size Availability Related information Reason
Current Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-02) NDC 63323-0280-02 Available Check wholesalers for inventory
Current Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-04) NDC 63323-0280-04 Available Check wholesalers for inventory
Current Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-10) NDC 63323-0280-10 Available Check wholesalers for inventory
Manufacturer: Gland Pharma Limited 📞 866-625-1618 6 NDCS click to expand
Status NDC / product Strength / size Availability Related information Reason
Current Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-02) NDC 25021-0311-02 Unavailable Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product Discontinuation of the manufacture of the drug
Current Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-10) NDC 25021-0311-10 Unavailable Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product Discontinuation of the manufacture of the drug
Current Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-04) NDC 25021-0311-04 Unavailable Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product Discontinuation of the manufacture of the drug
To Be Discontinued Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-04) NDC 25021-0311-04 Distributed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug
To Be Discontinued Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-02) NDC 25021-0311-02 Distributed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug
To Be Discontinued Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-10) NDC 25021-0311-10 Distributed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug
Manufacturer: Hospira, Inc., a Pfizer Company 📞 844-646-4398 6 NDCS click to expand
Status NDC / product Strength / size Availability Related information Reason
Current Furosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-27) NDC 00409-6102-27 Unavailable Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay Other
Current Furosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-04) NDC 00409-6102-04 Available
Current Furosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-26) NDC 00409-6102-26 Unavailable Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay Other
Current Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-02) NDC 00409-6102-02 Available
Current Furosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-10) NDC 00409-6102-10 Available
Current Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-25) NDC 00409-6102-25 Unavailable Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay Other
Manufacturer: Meitheal Pharmaceuticals, Inc. 📞 844-824-8426 3 NDCS click to expand
Status NDC / product Strength / size Availability Related information Reason
Current Furosemide, Injection, 10 mg/1 mL (NDC 71288-203-11) NDC 71288-0203-11 Available Check wholesalers for inventory
Current Furosemide, Injection, 10 mg/mL, 2 mL (NDC 71288-205-03) NDC 71288-0205-03 Available Check wholesalers for inventory
Current Furosemide, Injection, 10 mg/1 mL (NDC 71288-203-05) NDC 71288-0203-05 Available Check wholesalers for inventory

These rows are manufacturer reports to the FDA for Furosemide Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Furosemide Injection? options further down this page.

Why is Furosemide Injection in shortage?

Furosemide injection is on the FDA shortage list for several different reasons, depending on the manufacturer. Gland Pharma (distributed by Sagent Pharmaceuticals) has permanently stopped making their 10 mg/1 mL vials — this isn't a temporary delay, those specific products are discontinued. Accord Healthcare's 10 mg/1 mL vials are currently unavailable due to issues meeting FDA manufacturing standards (called "good manufacturing practices"), with no recovery date set yet. Avet Pharmaceuticals also has two of their 10 mg/1 mL package sizes on hold because of a manufacturing delay, with an estimated return around the end of October 2026 — though one of their 10 mg/1 mL sizes is still available.

Hospira (a Pfizer company) is dealing with manufacturing delays as well — their 20 mg/2 mL and 40 mg/4 mL vials (in certain package sizes) aren't expected back until December 2027, and one of their 100 mg/10 mL package sizes not until December 2028, though some other Hospira package sizes of those same strengths are still available. On top of all this, Eugia US LLC's 20 mg/2 mL vials are on backorder due to higher-than-usual demand, with no set return date — while their 40 mg/4 mL and 100 mg/10 mL sizes remain available. So the shortage is really a combination of factory hold-ups, manufacturing standards issues, permanently stopped products, and increased demand all hitting at once across multiple makers.

FDA reason code(s): Other; Requirements related to complying with good manufacturing practices; Discontinuation of the manufacture of the drug; Demand increase for the drug

Based on the manufacturer-reported reason(s) and notes on file with the FDA for Furosemide Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.

What should I do if I take Furosemide Injection?

Furosemide Injection is currently on the FDA drug-shortage list, and this shortage has lasted more than a year. Most strengths still have a supply, so it helps to know exactly which one you use.

Right now, the 20 mg/2 mL presentation from one filer has no available source and is on backorder with recovery listed as to-be-determined. The other strengths — including 40 mg/4 mL, 10 mg/1 mL, 100 mg/10 mL, and the 20 mg/2 mL (10 mg/1 mL) and 2 mL products — still show supply from at least one maker, though a few individual items list later recovery dates. Six of the eight manufacturers on this record still report available product. The reported reasons include manufacturing and quality-related requirements, higher demand, and one maker discontinuing its product. Because several companies still supply this medicine, an interruption does not mean it is gone everywhere.

Here is what I suggest:

  • Do not stop, skip, or change how this medicine is given on your own.
  • If your strength still has supply, ask your pharmacy to order it — pharmacies can check wholesalers and other manufacturers.
  • The same medicine is made by several other companies; your pharmacy may be able to source one, though it may not be in local stock.
  • If your exact strength cannot be found or is discontinued, ask your prescriber or pharmacist about options, such as a different strength to make up the dose.

Manufacturer contact numbers are listed on this page for reference; pharmacies usually handle those calls. This is national, manufacturer-reported data and may not match your local pharmacy's actual stock.

See “Where else can I get Furosemide Injection?” below ↓ The same medicine from manufacturers not reporting a shortage, alternative dosage forms, and therapeutic equivalents with pricing.
If you are a patient:
  • Don’t stop or change the medication on your own — talk to your prescriber first.
  • If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
  • Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
  • Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Keep reading
Our full Furosemide guide

Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.

Read the Furosemide guide →

Where else can I get Furosemide Injection?

FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Furosemide Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Same medicine, other manufacturers (not reported short)

Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:

ProductStrengthForm / routeManufacturerNDC
Furosemide FUROSEMIDE 10 mg/mL Injection · Intramuscular, Intravenous Hikma Pharmaceuticals USA Inc. 00143-9155-25
Furosemide FUROSEMIDE 10 mg/mL Injection, Solution · Intravenous Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 23155-0473-43
Furosemide FUROSEMIDE 10 mg/mL Injection, Solution · Intramuscular, Intravenous Sagent Pharmaceuticals 25021-0320-02
Furosemide FUROSEMIDE 10 mg/mL Injection, Solution · Intravenous Camber Pharmaceuticals, Inc. 31722-0309-32
Furosemide FUROSEMIDE 10 mg/mL Injection, Solution · Intravenous Baxter Healthcare Corporation 36000-0063-05
Furosemide FUROSEMIDE 10 mg/mL Injection, Solution · Intramuscular, Intravenous Fresenius Kabi USA, LLC 63323-0280-16
Furosemide FUROSEMIDE 100 mg/10mL Injection · Intramuscular, Intravenous Amneal Pharmaceuticals LLC 70121-1076-05
Furosemide FUROSEMIDE 20 mg/2mL Injection · Intramuscular, Intravenous Amneal Pharmaceuticals LLC 70121-1163-05
Furosemide FUROSEMIDE 40 mg/4mL Injection · Intramuscular, Intravenous Amneal Pharmaceuticals LLC 70121-1164-05
Furosemide FUROSEMIDE 10 mg/mL Injection, Solution · Intravenous REMEDYREPACK INC. 70518-4444-00
Furosemide FUROSEMIDE 10 mg/mL Injection, Solution · Intravenous Lifestar Pharma LLC 70756-0618-05
Furosemide FUROSEMIDE 10 mg/mL Injection, Solution · Intramuscular, Intravenous Meitheal Pharmaceuticals Inc. 71288-0203-03

Alternative dosage forms of Furosemide

A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:

Therapeutic equivalents & pricing 30 productsclick to expand

Orange Book–rated equivalents of the affected strengths / sizes, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.

ProductManufacturerPackageNADAC $/unitAB ratingAvailability
Furosemide 10 mg/mLNDC 31722-0310-32 Camber 25 vials $0.266 AP Availability likely
Furosemide 10 mg/mLNDC 36000-0283-25 Baxter 25 vials $0.266 AP Availability likely
Furosemide 40 mg/4mLNDC 55150-0323-25 Eugia 25 vials $0.266 AP Availability likely
Furosemide 10 mg/mLNDC 72572-0190-25 Civica, 25 vials $0.266 AP Availability likely
Furosemide 10 mg/mLNDC 72603-0251-25 NorthStar 25 vials $0.266 AP Availability likely
Furosemide 10 mg/mLNDC 73043-0023-01 Devatis 25 vials $0.266 AP Availability likely
Furosemide 10 mg/mLNDC 00143-9159-01 Hikma 1 vial $0.266 AP Availability likely
Furosemide 10 mg/mLNDC 00143-9157-10 Hikma 10 vials $0.266 AP Availability likely
Furosemide 10 mg/mLNDC 16729-0502-43 Accord 10 vials $0.342 AP Availability likely
Furosemide 10 mg/mLNDC 16729-0500-08 Accord 25 vials $0.415 AP Availability likely
Furosemide 10 mg/mLNDC 00409-6102-02 Hospira, 25 vials $0.462 AP Availability likely
Furosemide 10 mg/mLNDC 23155-0473-41 Heritage 25 vials $0.462 AP Availability likely
Furosemide 10 mg/mLNDC 25021-0311-02 Sagent 25 vials $0.462 AP Availability likely
Furosemide 10 mg/mLNDC 25021-0320-02 Sagent 25 vials $0.462 AP Availability likely
Furosemide 10 mg/mLNDC 63323-0280-02 Fresenius 25 vials $0.462 AP Availability likely
Furosemide 10 mg/mLNDC 71288-0203-03 Meitheal 25 vials $0.462 AP Availability likely
Furosemide 10 mg/mLNDC 83634-0302-02 Avenacy 25 vials $0.462 AP Availability likely
Furosemide 10 mg/mLNDC 81565-0201-02 Phlow 25 vials $0.462 AP Availability likely
Furosemide 10 mg/mLNDC 00143-9158-01 Hikma 1 vial $0.462 AP Availability likely
Furosemide 10 mg/mLNDC 00143-9155-25 Hikma 25 vials $0.462 AP Availability likely
Furosemide 10 mg/mLNDC 31722-0309-32 Camber 25 vials $0.462 +11% AP Availability likely
Furosemide 10 mg/mLNDC 36000-0282-25 Baxter 25 vials $0.462 +11% AP Availability likely
Furosemide 20 mg/2mLNDC 55150-0322-25 Eugia 25 vials $0.462 +11% AP Availability likely
Furosemide 10 mg/mLNDC 72603-0133-25 NorthStar 25 vials $0.462 +11% AP Availability likely
Furosemide 10 mg/mLNDC 73043-0022-01 Devatis 25 vials $0.462 +11% AP Availability likely
Furosemide 10 mg/mLNDC 00143-9156-10 Hikma 10 vials AP FDA listed
Furosemide 10 mg/mLNDC 00404-9863-04 Henry 1 vial AP FDA listed
Furosemide 10 mg/mLNDC 16729-0501-43 Accord 10 vials AP FDA listed
Furosemide 10 mg/mLNDC 36000-0064-05 Baxter 5 vials AP FDA listed
Furosemide 40 mg/4mLNDC 42571-0437-66 Micro 25 vials AP FDA listed

Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.

Other drugs in the same treatment class

These are different medicines — not other versions of Furosemide Injection — that fall in the same broad treatment class (loop diuretics) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.

Identity & classification

GCN Seq No 008205
GCN 34940
HICL code 003660
Ingredient (HICL) Furosemide
HIC1 code R
Therapeutic class — broad (HIC1) Kidney/Urinary Tract
HIC2 code R1
Therapeutic class — intermediate (HIC2) Affect Primarily Kidneys/Urinary Tract
HIC3 code R1M
Therapeutic class — specific (HIC3) Loop Diuretics
AHFS code 24:36.08.00
AHFS class Loop Diuretics (24:36)
FDB label name FUROSEMIDE 40 MG/4 ML VIAL
FDB brand name Furosemide
Legend status F — Federal legend — prescription drug or device
GPI-1437200030002005
GPI classFurosemide
Where does this data come from?
Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Other cardiovascular shortages

Furosemide Injection shortage FAQs

Is Furosemide Injection in shortage?
Yes — the FDA currently lists Furosemide Injection in shortage (status: “Current”, first reported Apr 7, 2020). 30 of 30 products are affected. This is national, manufacturer-reported data, so your pharmacy may still have stock.
Why is Furosemide Injection in shortage?
The manufacturer-reported reason on file with the FDA: Other; Requirements related to complying with good manufacturing practices; Discontinuation of the manufacture of the drug.
Which products are affected?
Furosemide, Injection, 10 mg/1 mL (NDC 16729-501-43) (NDC 16729-0501-43); Furosemide, Injection, 10 mg/1 mL (NDC 16729-500-08) (NDC 16729-0500-08); Furosemide, Injection, 10 mg/1 mL (NDC 16729-502-43) (NDC 16729-0502-43). The full per-NDC list (availability, manufacturer and status) is in the table above — each NDC links to its own page.
When will Furosemide Injection be available again?
The FDA does not publish a guaranteed restock date, and no estimated-recovery note is on file. Availability can change daily — confirm with your pharmacy.
Can I still get Furosemide somewhere?
Other manufacturers (Hikma Pharmaceuticals USA Inc., Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., Sagent Pharmaceuticals and others) still market it and have not reported a shortage. 9 alternative dosage forms of Furosemide are also listed. See “Where else can I get Furosemide Injection?” above — stock still varies by pharmacy.
What should I do if I take Furosemide Injection?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another manufacturer or a different strength/package size, and ask your prescriber about a long-term plan before your supply runs out.

Still have a question about the Furosemide Injection shortage?

Ask a pharmacist about this shortage →
How to read the Supply-Risk rating
Low (1–2)Multiple manufacturers still supplying and most strengths or pack sizes sourceable.
Medium (3)Some constraint — fewer suppliers or a notable share of NDCs unavailable.
High (4–5)Down to a single source, most strengths or pack sizes unsourceable, or a long-running outage.
Where does this data come from?
Shortage records come from the FDA Drug Shortages Database API via openFDA (/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.
Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD.
← Back to all current drug shortages